|
Lamotrigine Pregnancy Registry Please note that this registry is now CLOSED FOR NEW ENROLMENTS The Lamotrigine Pregnancy Registry has met its enrolment goal and as such, the Lamotrigine Pregnancy Registry Advisory Committee and GlaxoSmithKline closed the Registry to new registrations as of 03 June 2009. However, the Registry will be pursuing follow-up on existing Lamotrigine pregnancy cases through 31 March 2010. The Registry will continue to monitor retrospective reports of outcomes with defects through 31 March 2010. An Interim Report will not be issued in January 2010; rather, a Final Report will be issued in July 2010. We wish to thank everyone for their support of the Registry and helping the Registry achieve its goals. Your efforts in sending us registrations, follow-up information, and additional targeted follow-up information have been integral to the success of the Registry! If you have any questions, please don't hesitate to contact the Registry at 1-800-336-2176. For questions related to Lamotrigine exposure during pregnancy or other questions, please contact GlaxoSmithKline’s Response Center at 1-888-825-5249. Patients can still enroll themselves into the North American AED Pregnancy Registry by calling 1-888-233-2334 (toll-free). Follow-up form for Lamotrigine Pregnancy Registry (PDF format) Most recent interim report for Lamotrigine (PDF format) Additional resources: |
|